CD8A and neoplasm: Tumor microenvironment analysis showed that PD-1 was highly expressed on neoantigen-specific CD8+ T cells in the tumor compared to the spleen, thereby providing strong rationale for combination of vaccination with anti-PD-1 treatment (Fig. 4F).